Article Information
History
- March 22, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Sarah Steeg, PhD, Presidential Research Fellow*,1,2,
- Matthew J Carr, PhD, Research Fellow*,1,2,3,4,
- Laszlo Trefan, PhD, Research Fellow,
- Darren M Ashcroft, PhD FRPharmS, Professor of Pharmacoepidemiology1,2,3,4,
- Nav Kapur, FRCPsych, MD, Professor of Psychiatry and Population Health1,2,4,5,
- Emma Nielsen, BSc, Research Fellow6,
- Brian McMillan, PhD, MD, Clinical Lecturer1,7 and
- Roger T Webb, PhD, Professor of Mental Health Epidemiology1,2,4
- 1Centre for Mental Health and Safety, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK
- 2Manchester Academic Health Science Centre, University of Manchester, Manchester, UK
- 3Centre for Pharmacoepidemiology and Drug Safety, National Institute for Health Research Greater Manchester Patient Safety Translational Research Centre, University of Manchester, Manchester, UK
- 4National Institute for Health Research Greater Manchester Patient Safety Translational Research Centre, University of Manchester, Manchester, UK
- 5Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK
- 6Self-harm Research Group, School of Psychology, University of Nottingham, UK
- 7Centre for Primary Care and Health Services Research, University of Manchester, Manchester, UK
- * Corresponding author; email: sarah.steeg{at}manchester.ac.uk
Posted March 22, 2021.
Primary care clinical management following self-harm during the first wave of COVID-19 in the UK
